{
    "nctId": "NCT05633342",
    "briefTitle": "Project CADENCE (CAncer Detected Early caN be CurEd)",
    "officialTitle": "Development and Validation of a Blood Test for Screening and Early Detection of Multiple Cancers Based on Circulating Cell-free Nucleic Acid Profiles - Project CADENCE (CAncer Detected Early caN be CurEd)",
    "overallStatus": "RECRUITING",
    "conditions": "Thoracic Cancer, Ovarian Cancer, Liver Cancer, Prostate Cancer, Gastric Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, Pancreatic Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 15000,
    "primaryOutcomeMeasure": "To discover novel intracellular RNA and methylated DNA cancer biomarkers in fresh frozen tumor tissues.",
    "eligibilityCriteria": "Inclusion Criteria:\n\nHealthy average-risk cohort Individuals representing the general population who self-declare to have no cancer history and have no indications suggestive of underlying cancer development. Subjects will be recruited from a state-of-the-art population study.\n\nIncreased-risk (genetic/familial) cohort Individuals carrying certain germline mutations that predispose the subjects to an increased risk of having cancer than the general population. Subjects will be recruited from Cancer Genetics Service (CGS).\n\nHigh-risk cohort Individuals diagnosed with diseases that have a high risk of progressing to cancer.\n\nMalignant cohort Individuals diagnosed with cancer. Wherever possible, samples for the 'Malignant group' should have a representation of each cancer stage.\n\nExclusion Criteria:\n\nPregnant or lactating (self-declaration), unwilling or unable to provide signed informed consent and has or had received chemotherapy or radiotherapy for cancer treatment and/or any other cancer-related treatment.",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}